Senolytic CAR-T Shows Promise for Age-Related Diseases

https://www.medscape.com/viewarticle/senolytic-car-t-shows-promise-age-related-diseases-2026a10012jk?src= Chimeric antigen receptor (CAR) T-cell therapy has transformed the treatment of certain hematologic cancers. Researchers are now exploring whether this technology could also identify and eliminate senescent cells, which accumulate with age and may contribute to conditions such as diabetes, Alzheimer’s disease, and liver fibrosis.